Brain iron-related MRI signals and response to repeated ketamine in treatment-resistant depression

The question

Can brain scan measures that reflect iron levels, taken before treatment, predict how much someone’s depression improves with repeated ketamine infusions?

What they did

Researchers in Japan used data from a double-blind, placebo-controlled trial of repeated intravenous ketamine for treatment-resistant depression, plus an extended open-label phase where everyone received ketamine. Seventeen patients (7 women, average age 42.9 years) had MRI brain scans before receiving ketamine. The scans used two techniques, quantitative susceptibility mapping and R2* mapping, that estimate how much iron has built up in different brain regions. The team then tested statistically whether these baseline measures related to changes in depression scores on the Montgomery-Asberg Depression Rating Scale (MADRS), a standard clinician-rated scale, and its symptom subgroups.

What they found

Two associations stood out. Baseline magnetic susceptibility in the right nucleus accumbens, a brain region involved in motivation and reward, was negatively correlated with change in MADRS retardation symptom scores (slowed thinking and movement), with a standardized coefficient of -0.73 and a p-value of 0.003. Baseline R2* in the left amygdala, a region involved in emotional processing, was negatively associated with change in MADRS vegetative symptom scores such as sleep and appetite (coefficient -0.71, p = 0.004). The authors suggest these iron-sensitive measures may act as markers of who responds to repeated ketamine infusions.

The fine print

Only 17 people were included, which is very small for brain imaging work, and several brain regions and symptom subscores were tested, raising the chance of findings appearing by chance. The analysis combined patients from a placebo-controlled phase and an open-label phase, so it is not itself a controlled comparison, and no overall MADRS total score result is reported in the abstract. The iron measures are indirect surrogates rather than direct measurements of dopamine function, and this summary is based only on the published abstract.

What it means

This early exploratory work suggests that MRI measures related to brain iron might one day help predict who responds to ketamine, but the sample is far too small to guide any clinical decisions.

Evidence grade: Very low. A small biomarker analysis of just 17 people drawn from two phases of a ketamine study, with multiple brain regions and symptom subscores examined, so findings are exploratory.

This summary is based on the study’s published abstract.